Authors:
COMBEAU C
KENIGSBERG M
BAZIN V
LAVELLE F
MELKI R
Citation: C. Combeau et al., EXPRESSION OF GAMMA-TUBULIN AND THE CYTOPLASMIC CHAPERONIN CONTAININGTCP-1 (CCT) IN TUMOR-CELL LINES AND DURING CELL-PROLIFERATION - A COMPARATIVE-STUDY, Molecular biology of the cell, 9, 1998, pp. 874-874
Authors:
BISSERY MC
VRIGNAUD P
LAVELLE F
CHABOT GG
Citation: Mc. Bissery et al., EXPERIMENTAL ANTITUMOR-ACTIVITY AND PHARMACOKINETICS OF THE CAMPTOTHECIN ANALOG IRINOTECAN (CPT-11) IN MICE, Anti-cancer drugs, 7(4), 1996, pp. 437-460
Authors:
ROCHEFORT P
CAILLOU B
MICHIELS FM
LEDENT C
TALBOT M
SCHLUMBERGER M
LAVELLE F
MONIER R
FEUNTEUN J
Citation: P. Rochefort et al., THYROID PATHOLOGIES IN TRANSGENIC MICE EXPRESSING A HUMAN ACTIVATED RAS GENE DRIVEN BY A THYROGLOBULIN PROMOTER, Oncogene, 12(1), 1996, pp. 111-118
Authors:
BISSERY MC
NOHYNEK G
SANDERINK GJ
LAVELLE F
Citation: Mc. Bissery et al., DOCETAXEL (TAXOTERE(R)) - A REVIEW OF PRECLINICAL AND CLINICAL-EXPERIENCE .1. PRECLINICAL EXPERIENCE, Anti-cancer drugs, 6(3), 1995, pp. 339-355
Authors:
NGUYEN CH
FAN E
RIOU JF
BISSERY MC
VRIGNAUD P
LAVELLE F
BISAGNI E
Citation: Ch. Nguyen et al., SYNTHESIS AND BIOLOGICAL EVALUATION OF AMINO-SUBSTITUTED BENZO[F]PYRIDO[4,3-B] AND PYRIDO[3,4-B]QUINOXALINES - A NEW CLASS OF ANTINEOPLASTIC AGENTS, Anti-cancer drug design, 10(4), 1995, pp. 277-297
Authors:
MAILLIET P
SEGALBENDIRDJIAN E
KOZELKA J
BARREAU M
BAUDOIN B
BISSERY MC
GONTIER S
LAOUI A
LAVELLE F
LEPECQ JB
CHOTTARD JC
Citation: P. Mailliet et al., ASYMMETRICALLY SUBSTITUTED ETHYLENEDIAMINE PLATINUM(II) COMPLEXES AS ANTITUMOR AGENTS - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS, Anti-cancer drug design, 10(1), 1995, pp. 51-73
Citation: Mc. Bissery et al., PRECLINICAL PROFILE OF DOCETAXEL (TAXOTERE) - EFFICACY AS A SINGLE-AGENT AND IN COMBINATION, Seminars in oncology, 22(6), 1995, pp. 3-16
Authors:
OJIMA I
DUCLOS O
KUDUK SD
SUN CM
SLATER JC
LAVELLE F
VEITH JM
BERNACKI RJ
Citation: I. Ojima et al., SYNTHESIS AND BIOLOGICAL-ACTIVITY OF 3'-ALKYL-3'-DEPHENYLDOCETAXEL AND 3'-ALKENYL-3'-DEPHENYLDOCETAXEL, Bioorganic & medicinal chemistry letters, 4(21), 1994, pp. 2631-2634
Authors:
OJIMA I
DUCLOS O
ZUCCO M
BISSERY MC
COMBEAU C
VRIGNAUD P
RIOU JF
LAVELLE F
Citation: I. Ojima et al., SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF NEW ANTITUMOR TAXOIDS - EFFECTS OF CYCLOHEXYL SUBSTITUTION AT THE C-3' AND OR C-2 OF TAXOTERE (DOCETAXEL)/, Journal of medicinal chemistry, 37(16), 1994, pp. 2602-2608
Authors:
NABIEV I
CHOURPA I
RIOU JF
NGUYEN CH
LAVELLE F
MANFAIT M
Citation: I. Nabiev et al., MOLECULAR-INTERACTIONS OF DNA TOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITOR WITH DNA AND TOPOISOMERASES AND IN TERNARY COMPLEXES - BINDINGMODES AND BIOLOGICAL EFFECTS FOR INTOPLICINE DERIVATIVES, Biochemistry, 33(30), 1994, pp. 9013-9023
Authors:
BISSERY MC
NGUYEN CH
BISAGNI E
VRIGNAUD P
LAVELLE F
Citation: Mc. Bissery et al., ANTITUMOR-ACTIVITY OF INTOPLICINE (RP-60475, NSC-645008), A NEW BENZOPYRIDO-INDOLE - EVALUATION AGAINST SOLID TUMORS AND LEUKEMIAS IN MICE, Investigational new drugs, 11(4), 1993, pp. 263-277
Citation: B. Poddevin et al., DUAL TOPOISOMERASE-I AND TOPOISOMERASE-II INHIBITION BY INTOPLICINE (RP-60475), A NEW ANTITUMOR AGENT IN EARLY CLINICAL-TRIALS, Molecular pharmacology, 44(4), 1993, pp. 767-774
Authors:
RIOU JF
FOSSE P
NGUYEN CH
LARSEN AK
BISSERY MC
GRONDARD L
SAUCIER JM
BISAGNI E
LAVELLE F
Citation: Jf. Riou et al., INTOPLICINE (RP-60475) AND ITS DERIVATIVES, A NEW CLASS OF ANTITUMOR AGENTS INHIBITING BOTH TOPOISOMERASE-I AND TOPOISOMERASE-II ACTIVITIES, Cancer research, 53(24), 1993, pp. 5987-5993
Authors:
MORJANI H
RIOU JF
NABIEV I
LAVELLE F
MANFAIT M
Citation: H. Morjani et al., MOLECULAR AND CELLULAR INTERACTIONS BETWEEN INTOPLICINE, DNA, AND TOPOISOMERASE-II STUDIED BY SURFACE-ENHANCED RAMAN-SCATTERING SPECTROSCOPY, Cancer research, 53(20), 1993, pp. 4784-4790
Authors:
RIOU JF
GRONDARD L
PETITGENET O
ABITBOL M
LAVELLE F
Citation: Jf. Riou et al., ALTERED TOPOISOMERASE-I ACTIVITY AND RECOMBINATION ACTIVATING GENE-EXPRESSION IN A HUMAN LEUKEMIA-CELL LINE RESISTANT TO DOXORUBICIN, Biochemical pharmacology, 46(5), 1993, pp. 851-861